Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today announced that it was awarded a Standing Offer from the Canadian Air Transport Security Authority (CATSA) for up to 340 of its industry-leading QS-B220 desktop explosives trace detectors. These systems are to be deployed over the course of approximately the next two years to Canadian airports for passenger and baggage screening.
Implant Sciences' ETDs have been deployed to more than 160 airports over the last year. This order is in addition to the QS-B220 win last year of CATSA's competitive bid for 112 ETDs.
"Our robust systems, continue to be deployed in airports globally, deliver highly accurate and effective screening to the traveling public," stated Todd Swearingen , General Manager, Americas for Implant Sciences. "We pride ourselves in supporting the mission of safeguarding passengers around the world, and we are excited to have been selected again by CATSA."
Key data points: The market size in 2031 = $6.9 billion, growth forecast = 3.8% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global flight inspection market to 2031 by solution (service and system), end use (commercial airports, defense airports, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)
Download free sample pages"Our goal, as the pioneers of non-rad ETD, is to advance our products to meet the evolving needs of our customers and to surpass the performance and detection limitations of legacy trace detectors that are currently fielded," added Dr. Darryl Jones , Implant Sciences' Executive Vice President. "Implant Sciences' market share capture continues in North America and in the rest of the world. High-profile customers, like CATSA, repeatedly selecting our ETD solutions is the strongest endorsement we can receive."
